An investor in NYSE:OME shares filed a lawsuit over alleged Securities Laws violations by Omega Protein Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Omega Protein Corporation (NYSE:OME) have certain options and for certain investors are short and strict deadlines running. Deadline: May 1, 2017. NYSE:OME investors should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
Omega Protein Corporation reported that its annual Total Revenue increased from $308.63 million in 2014 to $390.83 million in 2016 while its Net Income rose from $18.46 million in 2014 to $32.91 million in 2016. Shares of Omega Protein Corporation (NYSE:OME) grew from $$16.34 per share in April 2016 to $26.55 per share in January 2017.
On March 1, 2017, Omega Protein Corporation disclosed that in December 2016 it had received a subpoena from the Securities and Exchange Commission (“SEC”) seeking information in connection with an investigation of an Omega Protein Corporation subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees. Shares of Omega Protein Corporation (NYSE:OME) declined from $26.40 per share on March 1, 2017, to as low as $18.35 per share on March 3, 2017.
According to the complaint the plaintiff alleges on behalf of purchasers of Omega Protein Corporation (NYSE:OME) common shares between June 4, 2013 and March 1, 2017, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 4, 2013 and March 1, 2017, the Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects, including: that Omega Protein’s subsidiary was potentially not in compliance with its probation terms, that the Company was not properly protecting whistleblower employees, that, as a result of the foregoing, the Company was vulnerable to an SEC investigation and potential civil and criminal liability, and that, as a result of the foregoing, Defendants’ statements about Omega Protein’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On March 27, 2017, NYSE:OME shares closed at $19.40 per share.
Those who purchased NYSE:OME shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego